$44.29
0.52%
NYSE, Fri, Dec 27 2024
ISIN
US1940141062
Symbol
CFX

Colfax Corporation Stock price

$44.29
-4.16 8.59% 1M
-0.62 1.38% 6M
-11.73 20.94% YTD
-12.33 21.78% 1Y
-139.51 75.90% 3Y
-100.91 69.50% 5Y
-166.47 78.99% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.23 0.52%
ISIN
US1940141062
Symbol
CFX
Sector

Key metrics

Market capitalization $2.47b
Enterprise Value $3.86b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.93
P/S ratio (TTM) P/S ratio 1.24
P/B ratio (TTM) P/B ratio 0.74
Revenue growth (TTM) Revenue growth 20.52%
Revenue (TTM) Revenue $2.00b
EBIT (operating result TTM) EBIT $-31.86m
Free Cash Flow (TTM) Free Cash Flow $-61.88m
Cash position $35.43m
EPS (TTM) EPS $-2.17
P/E forward negative
P/S forward 1.18
EV/Sales forward 1.84
Short interest 5.57%
Show more

Is Colfax Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Colfax Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Colfax Corporation forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Colfax Corporation forecast:

Buy
91%
Hold
9%

Financial data from Colfax Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,002 2,002
21% 21%
100%
- Direct Costs 1,019 1,019
23% 23%
51%
983 983
19% 19%
49%
- Selling and Administrative Expenses 662 662
19% 19%
33%
- Research and Development Expense 86 86
19% 19%
4%
235 235
18% 18%
12%
- Depreciation and Amortization 267 267
26% 26%
13%
EBIT (Operating Income) EBIT -32 -32
134% 134%
-2%
Net Profit -119 -119
32% 32%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Colfax Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.

Head office United States
CEO Matthew Trerotola
Employees 6,550
Founded 1995
Website www.enovis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today